Viracta Therapeutics (FRA:RYI) Shares Buyback Ratio % : -2.17 (As of Sep. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Viracta Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Viracta Therapeutics's current shares buyback ratio was -2.17%.

Viracta Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Viracta Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viracta Therapeutics Shares Buyback Ratio % Chart

Viracta Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

-1.16

-2.46

-1.95

Viracta Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Shares Buyback Ratio %	Get a 7-Day Free Trial													-0.44	-0.11	-1.21	-0.46	-0.37

Viracta Therapeutics Shares Buyback Ratio % Calculation

Viracta Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(38.3451	-	39.0935)	/	38.3451
	=	-1.95%

Viracta Therapeutics's Shares Buyback Ratio for the quarter that ended in Jun. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Mar. 2024 )	-	Shares Outstanding (EOP) (A: Jun. 2024 ))	/	Shares Outstanding (EOP) (A: Mar. 2024 )
	=	(39.2724	-	39.4172)	/	39.2724
	=	-0.37%

Viracta Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Viracta Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Viracta Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viracta Therapeutics Inc (FRA:RYI) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

VIRX:USA RYIS:Germany

Address

2533 South Coast Highway 101, Suite 210, Cardiff, CA, USA, 92007

Website

https://www.viracta.com

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants.